4//SEC Filing
Zung Jonathan B. 4
Accession 0001694665-22-000134
CIK 0001694665other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 4:32 PM ET
Size
5.4 KB
Accession
0001694665-22-000134
Insider Transaction Report
Form 4
Zung Jonathan B.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-07-19+115,000→ 115,000 totalExercise: $2.24Exp: 2032-07-19→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 50% of the underlying shares on the first anniversary of the date of grant, and as to the remaining 50% of the underlying shares on the second anniversary of the date of grant.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001837972
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 4:32 PM ET
- Size
- 5.4 KB